Industry-Leading Technologies Combined |
 | A new host cell line for the production of recombinant antibodies has been developed through close collaboration between Lonza and BioWa. The new cell line, Potelligent® CHOK1SV, combines the advantages of Lonza’s proprietary GS System™ and industry-leading cell line CHOK1SV with the power of BioWa’s engineered glycosylation Potelligent® Technology.
WATCH a recent presentation titled "Potelligent® CHOK1SV: The Evolution of the GS Gene Expression System™" delivered by Dr. Alison Porter, Senior Scientist. |
|
|
